Skip to main content

Table 2 Total and positive samples obtained in the two groups at each time-point for every site

From: Oral nystatin prophylaxis in surgical/trauma ICU patients: a randomised clinical trial

Sample

 

T0

T3

T6

T9

T12

T15

Trachea

Positive samples in group C

16

18

15

16

11

6

 

Positive samples in group N

11

16

12

11

5

1

 

Total samples obtained

99

81

72

53

33

22

Stomach

Positive samples in group C

29

27

26

16

15

7

 

Positive samples in group N

29

21

19

13

9

1

 

Total samples obtained

99

86

72

57

37

24

Pharynx

Positive samples in group C

23

23

20

18

13

7

 

Positive samples in group N

24

22

15

18

11

8

 

Total samples obtained

95

73

65

53

33

23

Skin

Positive samples in group C

2

3

8

6

6

4

 

Positive samples in group N

0

1

4

0

2

2

 

Total samples obtained

100

86

72

58

37

28

Rectum

Positive samples in group C

13

8

15

13

12

6

 

Positive samples in group N

6

7

12

8

1

1

 

Total samples obtained

95

79

72

57

33

24

Urine

Positive samples in group C

3

6

8

7

7

3

 

Positive samples in group N

5

5

5

4

1

0

 

Total samples obtained

99

86

72

59

36

28

Blood

Positive samples in group C

0

0

0

0

0

0

 

Positive samples in group N

0

0

0

0

0

0

 

Total samples obtained

99

86

72

59

37

28

  1. Group N, nystatin group; group C, control group.